Top-News

Tengion Aktie

Aktie
WKN:  A1JZR2 ISIN:  US88034G2084 US-Symbol:  TNGNQ
-    €
+0,00 €
+900,00%
-    $ 29.11.24
Handeln Depot/Watchlist
Aktienanzahl *
-
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-

Tengion News

07.08.13 - PR Newswire
Tengion Announces Promotion of A. Brian Davis to Chief Financial Officer and Senior Vice President, Finance
Tengion Announces Promotion of A. Brian Davis to Chief Financial Officer and Senior Vice President, Finance PR Newswire
01.07.13 - PR Newswire
Tengion Announces Transactions Totaling $33.6 Million to Advance its Organ Regeneration Platform™
Tengion Announces Transactions Totaling $33.6 Million to Advance its Organ Regeneration Platform™ $15 Million Strategic Investment from Celgene Corporation and $18.6 Million ...
12.06.13 - PR Newswire
Tengion to Participate in Panel Discussion at ISSCR 11th Annual Meeting
Tengion to Participate in Panel Discussion at ISSCR 11th Annual Meeting PR Newswire
15.05.13 - PR Newswire
Tengion Provides Business Update and Reports First Quarter 2013 Financial Results
Tengion Provides Business Update and Reports First Quarter 2013 Financial Results -- Phase 1 trial of Neo-​Kidney Augment™ on track for initiation in Sweden in second quarter of ...
01.04.13 - PR Newswire
Tengion Receives MPA Approval of CTA for Neo-Kidney Augment Phase 1 Trial in Sweden
Tengion Receives MPA Approval of CTA for Neo-​Kidney Augment Phase 1 Trial in Sweden PR Newswire
18.03.13 - PR Newswire
Tengion Provides Business Update and Reports Fourth Quarter and Full Year 2012 Financial Results
Tengion Provides Business Update and Reports Fourth Quarter and Full Year 2012 Financial Results -- Actively Recruiting for Neo-​Urinary Conduit™ Phase 1 Trial -- -- Neo-​Kidney ...
12.03.13 - PR Newswire
Tengion to Present at 25th Annual ROTH Conference
Tengion to Present at 25th Annual ROTH Conference PR Newswire
11.03.13 - PR Newswire
Tengion to Host Conference Call to Provide a Business Update and Report Fourth Quarter and Full Year 2012 Financial Results on March 18, 2013
Tengion to Host Conference Call to Provide a Business Update and Report Fourth Quarter and Full Year 2012 Financial Results on March 18, 2013 PR Newswire
05.02.13 - PR Newswire
Tengion to Present at the BIO CEO & Investor Conference
Tengion to Present at the BIO CEO & Investor Conference PR Newswire
30.01.13 - PR Newswire
Tengion Announces Clinical Progress for Neo-Urinary Conduit™ Phase 1 Trial and Regulatory Advance for Neo-Kidney Augment™
Tengion Announces Clinical Progress for Neo-​Urinary Conduit™ Phase 1 Trial and Regulatory Advance for Neo-​Kidney Augment™ -- Seventh Patient Implanted in Neo-​Urinary Conduit ...
21.12.12 - PR Newswire
Tengion Announces Change to Board of Directors
Tengion Announces Change to Board of Directors PR Newswire
13.11.12 - PR Newswire
Tengion Provides Business Update and Reports Third Quarter 2012 Financial Results
Tengion Provides Business Update and Reports Third Quarter 2012 Financial Results -- Actively Recruiting Remaining Four Patients in Neo-​Urinary Conduit™ Phase 1 Trial -- -- IND ...
08.11.12 - PR Newswire
Tengion Issued Additional Notice of Allowance for U.S. Patent Application Covering Cell-Scaffold Regeneration for its Neo-Urinary Conduit™ Product Candidate
Tengion Issued Additional Notice of Allowance for U.S. Patent Application Covering Cell-​Scaffold Regeneration for its Neo-​Urinary Conduit™ Product Candidate PR Newswire
07.11.12 - PR Newswire
Tengion to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
Tengion to Present at the Lazard Capital Markets 9th Annual Healthcare Conference PR Newswire
06.11.12 - PR Newswire
Tengion to Host Conference Call to Provide a Business Update and Report Third Quarter 2012 Financial Results on November 13, 2012
Tengion to Host Conference Call to Provide a Business Update and Report Third Quarter 2012 Financial Results on November 13, 2012 PR Newswire
05.11.12 - PR Newswire
Tengion Issued Notice of Allowance for U.S. Patent Application Covering Renal Regeneration for its Neo-Kidney Augment™ Product Candidate
Tengion Issued Notice of Allowance for U.S. Patent Application Covering Renal Regeneration for its Neo-​Kidney Augment™ Product Candidate PR Newswire
26.10.12 - PR Newswire
Tengion Provides Patient Update on its Neo-Urinary Conduit™ Clinical Program
Tengion Provides Patient Update on its Neo-​Urinary Conduit™ Clinical Program -- Company Reports Unrelated Deaths of Two Patients in its Ongoing Phase 1 Trial -- PR Newswire
10.10.12 - PR Newswire
Tengion Announces Closing of $15.0 Million of Senior Secured Convertible Notes Due 2015
Tengion Announces Closing of $15.0 Million of Senior Secured Convertible Notes Due 2015 -- Grants Option to Purchase Up to $20 Million in Additional Principal Amount of Notes -- ...
03.10.12 - PR Newswire
Tengion Announces Pricing of $15.0 Million of Senior Secured Convertible Notes Due 2015
Tengion Announces Pricing of $15.0 Million of Senior Secured Convertible Notes Due 2015 -- Expects Net Proceeds to Fund Company's Key Objectives for Lead Programs -- PR ...
05.09.12 - PR Newswire
Tengion Common Stock to Begin Trading on The OTCQB™ Tier of the OTC Marketplace on September 6, 2012
Tengion Common Stock to Begin Trading on The OTCQB™ Tier of the OTC Marketplace on September 6, 2012 -- The OTCQB is the Home to Approximately 3,500 Companies that are ...

Newssuche

Videos

newspaper
07:01 Uhr -5,97%
Technical Trading: Platin Top Saisonaler Trade
Platin Long Typ: Turbo Open End WKN: NG3NB2 Hebel: 7 Laufzeit: OpenEnd Einstieg: Market ... Mehr »